Anti-Firefly Luciferase 抗体 [EPR17789] - N-terminal (ab185923)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR17789] to Firefly Luciferase - N-terminal
- Suitable for: ICC/IF, WB, Flow Cyt
- Reacts with: Firefly
Related conjugates and formulations
製品の概要
-
製品名
Anti-Firefly Luciferase antibody [EPR17789] - N-terminal
Firefly Luciferase 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR17789] to Firefly Luciferase - N-terminal -
由来種
Rabbit -
アプリケーション
適用あり: ICC/IF, WB, Flow Cytmore details -
種交差性
交差種: Firefly
非交差種: Mouse, Rat -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: Firefly Luciferase transfected HEK-293 whole cell lysate. ICC/IF: Firefly Luciferase transfected HEK-293T cells.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
バッファー
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR17789 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab185923の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC/IF |
1/500.
|
|
WB |
1/2000. Detects a band of approximately 61 kDa (predicted molecular weight: 61 kDa).
|
|
Flow Cyt |
Use at an assay dependent concentration.
|
特記事項 |
---|
ICC/IF
1/500. |
WB
1/2000. Detects a band of approximately 61 kDa (predicted molecular weight: 61 kDa). |
Flow Cyt
Use at an assay dependent concentration. |
ターゲット情報
-
関連性
Luciferase from the firefly has become one of the more widely used reporter proteins for the study of gene expression. Luciferase catalyzes a bioluminescent reaction which requires the substrate luciferin as well as Mg2+ and ATP. Mixing these reagents with the cell extract containing luciferase, results in a flash of light that decays rapidly. This light can be detected by a luminometer. The total light emission is proportional to the luciferase activity of the sample. -
細胞内局在
Peroxisome -
参照データベース
- SwissProt: P08659 Firefly
-
別名
- ec 1.13.12.7 antibody
- Firefly antibody
- Luciferase antibody
- Luciferin 4 monooxygenase antibody
画像
-
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HEK-293T (Human epithelial cells from embryonic kidney) cells transfected with Empty vector or Firefly Luciferase, labeling Firefly Luciferase with ab185923 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Nuclear staining on HEK293T cells transfected with Firefly Luciferase is observed. The nuclear counter stain is DAPI (blue).
-
Flow Cytometry analysis of 293T (Human epithelial cell line from embryonic kidney) transfected with GFP tagged Firefly Luciferase cells labeling Firefly Luciferase with purified ab185923 at 1/200 dilution (10ug/ml, Right panel). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 647)(1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Left panel) was used as the isotype control.
-
All lanes : Anti-Firefly Luciferase antibody [EPR17789] - N-terminal (ab185923) at 1/2000 dilution
Lane 1 : Empty vector (vector control) transfected HEK293 (human embryonic kidney) whole cell lysate
Lane 2 : Firefly Luciferase transfected HEK293 (human embryonic kidney) whole cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 61 kDa
Observed band size: 61 kDa
Exposure time: 30 secondsBlocking and dilution buffer: 5% NFDM/TBST.
-
All lanes : Anti-Firefly Luciferase antibody [EPR17789] - N-terminal (ab185923) at 1/1000 dilution
Lane 1 : Firefly Luciferase transfected HEK293 (human embryonic kidney) whole cell lysate at 10 µg
Lane 2 : HeLa (human cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 3 : MCF-7 (human breast carcinoma) whole cell lysate at 20 µg
Lane 4 : Jurkat (human acute T cell leukemia) whole cell lysate at 20 µg
Lane 5 : SH-SY5Y (human neuroblastoma) whole cell lysate at 20 µg
Lane 6 : Human fetal heart lysate at 10 µg
Lane 7 : Human fetal kidney lysate at 10 µg
Lane 8 : Human fetal spleen lysate at 10 µg
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 61 kDa
Observed band size: 61 kDa
Exposure time: 3 minutesBlocking and dilution buffer: 5% NFDM/TBST.
-
All lanes : Anti-Firefly Luciferase antibody [EPR17789] - N-terminal (ab185923) at 1/1000 dilution
Lane 1 : Firefly Luciferase transfected HEK293 (human embryonic kidney) whole cell lysate
Lane 2 : Mouse brain lysate
Lane 3 : Mouse heart lysate
Lane 4 : Mouse kidney lysate
Lane 5 : Mouse spleen lysate
Lane 6 : Rat brain lysate
Lane 7 : Rat kidney lysate
Lane 8 : Rat spleen lysate
Lane 9 : C6 (rat glioma) whole cell lysate lysate
Lane 10 : Raw264.7 (mouse abelson murine leukemia virus-induced tumor) whole cell lysate
Lane 11 : PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate
Lane 12 : NIH/3T3 (mouse embryo) whole cell lysate
Lysates/proteins at 10 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Predicted band size: 61 kDa
Observed band size: 61 kDa
Exposure time: 3 minutesBlocking and dilution buffer: 5% NFDM/TBST.
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
Certificate of Compliance
参考文献 (8)
ab185923 は 8 報の論文で使用されています。
- Isobe S et al. Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension. Nat Commun 14:7578 (2023). PubMed: 37989727
- Svitkin YV et al. Membrane-dependent relief of translation elongation arrest on pseudouridine- and N1-methyl-pseudouridine-modified mRNAs. Nucleic Acids Res 50:7202-7215 (2022). PubMed: 34933339
- Zhang J et al. Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation. Sci Immunol 7:eabk2092 (2022). PubMed: 35119941
- Dong X et al. Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease. Genome Biol 21:238 (2020). PubMed: 32894206
- Azad T et al. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. Nat Commun 9:1061 (2018). WB . PubMed: 29535383
- Yan J et al. Molecular characterization of the giant freshwater prawn (Macrobrachium rosenbergii) beta-actin gene promoter. PeerJ 6:e5701 (2018). PubMed: 30386688
- Svitkin YV et al. N1-methyl-pseudouridine in mRNA enhances translation through eIF2a-dependent and independent mechanisms by increasing ribosome density. Nucleic Acids Res 45:6023-6036 (2017). PubMed: 28334758
- García-Dorival I et al. Elucidation of the Cellular Interactome of Ebola Virus Nucleoprotein and Identification of Therapeutic Targets. J Proteome Res 15:4290-4303 (2016). PubMed: 27786485